Anticoagulant Therapy Clinical Trials

6 recruiting

Anticoagulant Therapy Trials at a Glance

7 actively recruiting trials for anticoagulant therapy are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Beijing, Drammen, and Bergen. Lead sponsors running anticoagulant therapy studies include Guri Hagberg, Institute of Cardiovascular Diseases, Vojvodina, and Centre Hospitalier Universitaire de Besancon.

Browse anticoagulant therapy trials by phase

Treatments under study

About Anticoagulant Therapy Clinical Trials

Looking for clinical trials for Anticoagulant Therapy? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anticoagulant Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anticoagulant Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 4

Vitamin K for Perioperative Warfarin Management

Anticoagulant Therapy
University of Michigan20 enrolled1 locationNCT07515664
Recruiting
Not Applicable

Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture

Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION+2 more
Institute of Cardiovascular Diseases, Vojvodina200 enrolled1 locationNCT07360899
Recruiting
Phase 3

Thrombolysis in Factor Xa-inhibitors Trial

StrokeAcute Ischemic StrokeIschemic Stroke+6 more
Guri Hagberg300 enrolled13 locationsNCT06878066
Recruiting
Phase 1

Phase I Study of MT1011 Injection in Healthy Subjects

Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd.40 enrolled1 locationNCT07024160
Recruiting

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Anticoagulant TherapyCerebral Venous ThrombosisAnticoagulant Drugs+6 more
Xuanwu Hospital, Beijing1,486 enrolled1 locationNCT06947707
Recruiting

Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department

ThrombosisAnticoagulant TherapyHemorrhage+1 more
Centre Hospitalier Universitaire de Besancon2,080 enrolled1 locationNCT06692504
Recruiting

Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

Anticoagulant TherapyFemoral Neck FracturesOsteoperosis
Meir Hospital, Kfar Saba, Israel100 enrolled1 locationNCT06644976